Irvine, CA- July 1, 2014- AcuFocus (www.acufocus.com) the global leader in corneal inlay technology, announced today the appointment of Darin Dixon, as Director of Commercialization for the Americas. In this role, Mr. Dixon will be responsible for leading AcuFocus’ sales in Canada, Latin America and the United States for their groundbreaking technologies – the KAMRA™ inlay and the AcuTarget HD™ instrument.
Mr. Dixon brings with him over 20 years of sales experience and an impressive sales record within ophthalmology. A 10-year veteran of Abbott Medical Optics, and most recently Vice President of Sales for MST, Mr. Dixon has demonstrated great leadership in developing teams of professionals to sell some of the most innovative products currently on the market.
“I’ve had the pleasure of working with Darin at AMO and know he will be a great addition to the AcuFocus team. His wealth of experience, relationships and knowledge of the ophthalmic industry and products will be instrumental in our continued growth across the Americas,” said Jim Mazzo, Executive Chairman and Chief Executive Officer of AcuFocus, Inc.
The KAMRA™ inlay has gained broad acceptance worldwide as a long-lasting, reliable solution for near vision loss. The AcuTarget HD™, the newest addition to the AcuFocus family of products, combines five diagnostic tools into one state-of-the-art instrument to provide practices with new objective data to support patient selection, treatment centration and post-op patient management. “Both the KAMRA™ inlay and the AcuTarget HD™ instrument are both truly innovative technologies,” said Mr. Dixon. “I’m excited to develop and lead the America’s team, in order to bring these great products to the millions of patients who can benefit from them”.
About Presbyopia
Presbyopia occurs as part of the normal aging process and reduces the ability of the eye to focus on near objects. This condition occurs when the crystalline lens of the eye loses its flexibility, making it difficult to focus on close objects. Presbyopia may seem to occur suddenly, but the actual loss of flexibility takes place over a number of years, usually becoming noticeable in the early to mid-40’s. Presbyopia is not a disease and it cannot be prevented. Traditionally, most people with presbyopia use reading glasses to improve their near vision.
About AcuFocus
AcuFocus, Inc., a privately held company located in Irvine, CA, developed the KAMRA inlay for the treatment of near vision loss (presbyopia) and the AcuTarget HD diagnostic and planning instrument in collaboration with Visiometrics. The KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly while maintaining distance vision. By applying the “depth-of-focus” principle commonly used in photography, the KAMRA inlay controls light transmission, allowing only central rays to reach the retina through a fixed 1.6mm aperture. More than 20,000 KAMRA inlays have been implanted and it is available for sale in over 50 countries worldwide. The KAMRA inlay is not yet approved for sale in the United State and is pending FDA approval. The AcuTarget HD combines five diagnostic tools into one state-of-the-art instrument to provide practices with objective data to support patient selection, centration and post-operative management. The AcuTarget HD is available for sale in many countries worldwide, including the United States. For more information about the KAMRA inlay and AcuTarget HD™ from AcuFocus, please visit www.AcuFocus.com. KAMRA and AcuTarget HD are trademarks of AcuFocus, Inc.
Media Contact
Allison Potter
Pascale Communications, LLC
[email protected] (412) 228-1678